Free Cash Flow: A measure of financial performance calculated as operating cash flow minus capital expenditures. Calculated as: Cash Flow from Operations + Net Property, Plant & Equipment Exp (a negative number)
Sagimet Biosciences Inc. (SGMT) had Free Cash Flow of $-23.64M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-10.39M |
|
-- |
|
-- |
|
$11.93M |
|
$-11.93M |
|
$1.54M |
|
$-10.39M |
|
$-10.39M |
|
$-10.39M |
|
$-10.39M |
|
$-10.39M |
|
$-10.39M |
|
$-11.93M |
|
$-12.15M |
|
32.20M |
|
32.20M |
|
$-0.32 |
|
$-0.32 |
|
| Balance Sheet Financials | |
$127.20M |
|
-- |
|
$10.21M |
|
$137.41M |
|
$7.25M |
|
-- |
|
-- |
|
$7.25M |
|
$130.16M |
|
$130.16M |
|
$130.16M |
|
32.20M |
|
| Cash Flow Statement Financials | |
$-23.64M |
|
$-9.88M |
|
$0.00M |
|
$75.84M |
|
$42.33M |
|
$-33.51M |
|
$3.07M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
17.55 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Free Cash Flow |
$-23.64M |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-7.98% |
|
-7.98% |
|
-7.56% |
|
-7.98% |
|
$4.04 |
|
$-0.73 |
|
$-0.73 |
|